ATE110255T1 - Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums. - Google Patents

Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums.

Info

Publication number
ATE110255T1
ATE110255T1 AT88904835T AT88904835T ATE110255T1 AT E110255 T1 ATE110255 T1 AT E110255T1 AT 88904835 T AT88904835 T AT 88904835T AT 88904835 T AT88904835 T AT 88904835T AT E110255 T1 ATE110255 T1 AT E110255T1
Authority
AT
Austria
Prior art keywords
ghl
drug
derivatives
manufacture
hair growth
Prior art date
Application number
AT88904835T
Other languages
German (de)
English (en)
Inventor
Loren Ralph Pickart
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Application granted granted Critical
Publication of ATE110255T1 publication Critical patent/ATE110255T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)
AT88904835T 1987-05-11 1988-05-11 Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums. ATE110255T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4844487A 1987-05-11 1987-05-11

Publications (1)

Publication Number Publication Date
ATE110255T1 true ATE110255T1 (de) 1994-09-15

Family

ID=21954621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904835T ATE110255T1 (de) 1987-05-11 1988-05-11 Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums.

Country Status (11)

Country Link
US (1) US5135913A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0314755B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP2604457B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR960014776B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE110255T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1323839C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3851203T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK10389A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX169205B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO175616C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1988008695A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
AU633005B2 (en) * 1988-06-16 1993-01-21 Procyte Corporation Cosmetic and skin treatment compositions
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5252559A (en) * 1991-08-20 1993-10-12 The Procter & Gamble Company His-Gly-Gly peptide and derivatives thereof for hair growth
ES2221921T3 (es) * 1992-07-13 2005-01-16 Shiseido Company, Ltd. Composicion para preparacion dermatologica.
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
ES2101263T3 (es) * 1993-02-19 1997-07-01 Howard Green Composiciones que contienen proteinas de corneocitos.
US5425954A (en) * 1993-09-30 1995-06-20 Curafas Incorporated Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
AU2231495A (en) * 1994-03-28 1995-10-17 Skin Biology, Inc. Starch-metal complexes for skin and hair
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
US5735212A (en) * 1994-08-09 1998-04-07 Baldwin-Japan Ltd. Cylinder cleaning apparatus
US6001812A (en) * 1995-04-28 1999-12-14 Societe L'oreal S.A. Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
FR2733421B1 (fr) * 1995-04-28 1997-06-06 Oreal Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US5614489A (en) * 1995-05-25 1997-03-25 Mohammadi; Fatemeh Method and composition for treating the skin
US5866142A (en) * 1995-07-20 1999-02-02 Riordan; Neil H. Skin treatment system
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
US6958148B1 (en) * 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6267957B1 (en) 1998-01-20 2001-07-31 Howard Green Attaching agents to tissue with transglutaminase and a transglutaminase substrate
EP1061964B2 (en) * 1998-03-12 2009-10-28 The Procter & Gamble Company Proton donating actives in absorbent articles
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
CN1390231A (zh) 1999-10-01 2003-01-08 Dmi生物科学公司 金属－结合性化合物及其用途
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
KR100688910B1 (ko) * 2000-07-06 2007-03-08 주식회사 코리아나화장품 트리펩타이드 함유 립스틱 조성물
US20030166510A1 (en) * 2000-10-11 2003-09-04 Pickart Loren R. Methods and compositions for increasing skin remodeling
FR2826580B1 (fr) * 2001-06-29 2005-09-30 Oreal Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices
FR2826581B1 (fr) * 2001-06-29 2005-10-07 Oreal Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes
JP2005507904A (ja) * 2001-10-05 2005-03-24 プロサイト コーポレイション ペプチド銅錯体およびレチノール、レチノール誘導体、またはそれらの混合物を含むスキンケア組成物
WO2003047543A1 (en) * 2001-10-05 2003-06-12 Procyte Corporation Methods for the treatment of hyperpigmentation of skin
US20030148927A1 (en) * 2001-10-05 2003-08-07 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
EP1534215A1 (en) * 2002-07-02 2005-06-01 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
WO2004014413A1 (en) * 2002-07-31 2004-02-19 Procyte Corporation Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
US7128923B2 (en) 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
US6927205B2 (en) * 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
US6927206B2 (en) * 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
FR2857597B1 (fr) * 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
FR2857667B1 (fr) 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie
ES2390457T3 (es) * 2003-08-04 2012-11-13 Johnson & Johnson Consumer Companies, Inc. Métodos para el tratamiento de enfermedades dermatológicas
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US20060052287A1 (en) * 2004-08-18 2006-03-09 Procyte Corporation Polyethylene glycol - peptide copper complexes and compositions and methods related thereto
EP1809385B1 (en) 2004-11-09 2009-07-15 The Cupron Corporation Methods and materials for skin care
US20060216258A1 (en) 2005-03-24 2006-09-28 Singleton Laura C Water-in-silicone emulsion compositions
DE102005026069A1 (de) * 2005-06-07 2006-12-14 Goldschmidt Gmbh Topische kosmetische Formulierungen zur Regulierung und Verbesserung des Feuchtigkeitsgehalts der Haut
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
WO2008027984A1 (en) 2006-08-29 2008-03-06 Isolagen Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
ES2421262T3 (es) * 2007-11-30 2013-08-30 Evonik Goldschmidt Gmbh Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
CN102781406B (zh) 2010-03-01 2015-07-08 强生消费者公司 具有理想的整体颜色的护肤组合物
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
EP3542866A1 (en) * 2012-03-07 2019-09-25 Fibrocell Technologies, Inc. Topical dermal formulations and methods of personalized treatment of skin
TWI444197B (zh) * 2012-04-26 2014-07-11 Univ China Medical 用於改善皮膚老化之組合物
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194732A (en) * 1960-10-03 1965-07-13 Neuhauser Irene Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3758682A (en) * 1972-03-23 1973-09-11 Diagnostics Data Inc Pharmaceutical compositions comprising orgotein and their use
US3832338A (en) * 1972-03-23 1974-08-27 Diagnostic Data Inc Orgotein production using a buffer solution containing divalent metal salts
US4022888A (en) * 1975-09-09 1977-05-10 Diagnostic Data, Inc. Esterified orgotein
DE2700043C2 (de) * 1977-01-03 1983-12-08 Thera Gesellschaft für Patentverwertung mbH, 8036 Herrsching Mittel zur Verbesserung der Durchblutung und Wundheilung
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue
US4287184A (en) * 1977-11-23 1981-09-01 The Massachusetts General Hospital Process for healing wounds
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
HU193289B (en) * 1984-06-19 1987-09-28 Universal Vegyipari Szoevetkez Cosmetical composition for treating hair and nail containing blood plasma concentrate as active agent
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US4665054A (en) * 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu

Also Published As

Publication number Publication date
DE3851203T2 (de) 1994-12-15
MX169205B (es) 1993-06-24
JP2988876B2 (ja) 1999-12-13
AU1729688A (en) 1988-12-06
CA1323839C (en) 1993-11-02
US5135913A (en) 1992-08-04
WO1988008695A1 (en) 1988-11-17
AU609819B2 (en) 1991-05-09
JP2604457B2 (ja) 1997-04-30
DK10389D0 (da) 1989-01-11
EP0314755B1 (en) 1994-08-24
JPH02500367A (ja) 1990-02-08
KR890701079A (ko) 1989-12-19
DK10389A (da) 1989-01-11
DE3851203D1 (de) 1994-09-29
KR960014776B1 (en) 1996-10-19
NO890089D0 (no) 1989-01-10
NO175616B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-08-01
EP0314755A1 (en) 1989-05-10
JPH09278631A (ja) 1997-10-28
NO890089L (no) 1989-01-10
NO175616C (no) 1994-11-09

Similar Documents

Publication Publication Date Title
ATE110255T1 (de) Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums.
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE3860043D1 (de) Verwendung von biertreberextrakt zur herstellung von medizinischen und kosmetischen zubereitungen.
FI870578A7 (fi) Monikasvainkudosviipaleet ja näiden viipaleiden valmistusmenetelmät sekä niissä olevien kudosten testausmenetelmät.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
AT298664B (de) Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper
ATE38773T1 (de) Biologisches mittel zur behandlung der haare und der haut.
DE3373978D1 (en) Composition for the care or treatment of the human skin
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DE3765916D1 (de) Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde.
DE3276786D1 (en) Medical process and preparation
ATE42201T1 (de) Verwendung von phytosterolglycosiden zur herstellung von arzneimitteln zur behandlung von erhoehtem 5(6)alpha-epoxycholesterolgehalt.
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
DE3579642D1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee